For Fiscal Year Ending Dec 31, 2019
Receive updates straight into your inbox
Emerald Bioscience is a biopharmaceutical company headquartered in Long Beach, California, focused on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics for significant unmet medical needs in global markets. With proprietary technology licensed from the University of Mississippi, Emerald is developing novel ways to deliver cannabinoid-based drugs for specific indications with the aim of optimizing the clinical effects of such drugs while limiting potential adverse events. Emerald's strategy is to clinically develop a number of proprietary biosynthetic compounds, alone or in combination with corporate partners.
Emerald Bioscience, Inc.
130 North Marina Drive Long Beach, CA 90803
EMBI Investor Relations T: 949-396-0330 firstname.lastname@example.org
ClearTrust, LLC 16540 Pointe Village Dr. Suite 210 Lutz, FL 33558 T: 813-235-4490 www.ClearTrustOnline.com